<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">HPB Surg</journal-id>
      <journal-title>HPB Surgery</journal-title>
      <issn pub-type="ppub">0894-8569</issn>
      <issn pub-type="epub">1607-8462</issn>
      <publisher>
        <publisher-name>Hindawi Publishing Corporation</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta><article-id pub-id-type="pmid">7547620</article-id><article-id pub-id-type="pmc">2423778</article-id>
		<article-id pub-id-type="pii">S089485699596946X</article-id>
		<article-id pub-id-type="doi">10.1155/1995/96946</article-id>
	<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Repeated Hepatic Dearterialization for Unresectable Liver Metastases From Gastric Cancer: Review of Five Cases</article-title></title-group><contrib-group>
		<contrib contrib-type="author" corresp="yes"><name><surname>Kimoto</surname><given-names>Takeo</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Nagasue</surname><given-names>Naofumi</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Kohno</surname><given-names>Hitoshi</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Chang</surname><given-names>Yu-Chung </given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Taniura</surname><given-names>Hiroyuki</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Yamanoi</surname><given-names>Akira</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Uchida</surname><given-names>Masaaki</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Takemoto</surname><given-names>Yoshinari</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Makino</surname><given-names>Yoshinari</given-names></name></contrib>
		<contrib contrib-type="author"><name><surname>Nakamura</surname><given-names>Teruhisa</given-names></name></contrib>
	</contrib-group>
		<aff id="aff"><label/>
			<addr-line>From Second Department of Surgery</addr-line>
			<addr-line>Shimane Medical University</addr-line>
			<addr-line>Izumo</addr-line>
			<addr-line>693</addr-line>
			<country>Japan</country>
		</aff>
	<pub-date pub-type="ppub"><year>1995</year></pub-date><volume>8</volume><issue>3</issue><fpage>175</fpage><lpage>180</lpage><permissions><copyright-statement>Copyright &#xA9; 1995 Hindawi Publishing Corporation.</copyright-statement><copyright-year>1995</copyright-year><copyright-holder>Hindawi Publishing Corporation</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract>
		<p>A novel method of repeated hepatic dearterialization was evaluated in five patients with multiple
metastases from gastric cancer in both hepatic lobes. After gastrectomy with extensive lymph node
dissection (R2/3), all patients underwent implantation of a vascular occluder around the hepatic
artery. Cannulation of the hepatic artery was added for later chemotherapy. The hepatic artery was
occluded repeatedly for 1 hour twice daily in combination with intrahepatic infusion of anticancer
drugs for as long as possible. Three of five patients demonstrated marked tumour regression with
unexpectedly long survival (16 months in two patients and one still alive at 15 months).
Carcinoembryonic antigen (CEA) levels decreased to almost normal in four patients who had initially
high levels. The present experiences seems to indicate that long survival can be hoped for in patients
with advanced gastric cancer with unresectable liver metastases.</p>
	</abstract></article-meta>
  </front>
</article>
</pmc-articleset>
